Medical technology company Glucotrack will showcase its groundbreaking Continuous Blood Glucose Monitor (CBGM) technology during an upcoming virtual webinar, potentially offering diabetes patients a more advanced and less intrusive method of managing their condition.
The webinar, scheduled for May 29, will highlight Glucotrack's innovative approach to glucose monitoring, which differs significantly from traditional methods. Current diabetes management tools typically require patients to repeatedly prick their fingers throughout the day to obtain blood glucose readings, a process that can be both cumbersome and psychologically challenging.
Glucotrack's CBGM technology represents a substantial advancement in continuous glucose monitoring. Unlike existing devices that measure glucose through subcutaneous sensors with inherent time lags, Glucotrack's implantable device provides real-time blood glucose readings directly from the bloodstream. This approach could dramatically improve patient experience and medical management.
A key distinguishing feature of Glucotrack's technology is its extended usability. While many current continuous glucose monitors require sensor replacement every ten to ninety days, Glucotrack's implant can potentially function for two to three years. This longevity could significantly reduce patient burden and healthcare costs associated with frequent device replacements.
The company recently completed a preclinical study demonstrating the device's accuracy, achieving a Mean Absolute Relative Difference (MARD) of 4.7% at ninety days. Such precision is critical for effective diabetes management, as it enables patients to make more informed decisions about their health in real time.
The significance of this technology is underscored by global diabetes projections. By 2030, an estimated 643 million people worldwide are expected to be living with diabetes, a number projected to increase to 783 million by 2045. Innovative monitoring technologies like Glucotrack's CBGM could play a crucial role in improving patient outcomes and quality of life.
During the upcoming webinar, Glucotrack executives will provide comprehensive insights into their technology, including detailed explanations of how the CBGM works, updates on ongoing clinical trials, and a vision for the future of diabetes management. The event will conclude with a live question-and-answer session, allowing attendees to engage directly with the company's experts.
